Alignment Healthcare President Maroney Dawn Christine sold 122,707 shares at $12.68 per share on 2026-09-11. The transaction represented about 13.4% of her prior holding, leaving her with 794,606 shares, a direct change in the president’s ownership position for investors tracking ALHC.
Key Highlights
- The transaction used code S, identifying an open-market sale.
- Maroney Dawn Christine held 794,606 shares after the transaction.
- The sale represented about 13.4% of her prior shareholding.
Alignment Healthcare, Inc. (NASDAQ: ALHC) president Maroney Dawn Christine sold 122,707 shares at $12.68 per share on 11 September 2026.
$12.68 Share Sale on 11 September 2026
The reported ownership after the transaction was 794,606 shares. That figure describes the shares remaining after the transaction, rather than the 122,707 shares sold.
13.4% of Prior Holding
The transaction represented about 13.4% of Maroney Dawn Christine’s prior shares holding. The percentage is measured against her position before the sale, while 794,606 shares is the position reported afterward. The 13.4% figure is not a percentage of the post-transaction balance. It is the portion of the prior holding represented by the 122,707-share sale.
FAQs
Q: What did Alignment Healthcare president Maroney Dawn Christine sell?
A: Maroney Dawn Christine sold 122,707 Alignment Healthcare shares at $12.68 per share. The transaction occurred on 11 September 2026 and used transaction code S.
Q: How many Alignment Healthcare shares did Maroney Dawn Christine retain?
A: Maroney Dawn Christine owned 794,606 Alignment Healthcare shares after the transaction. The remaining balance reflects her reported position following the sale.
Q: What percentage of her holdings did the ALHC share sale represent?
A: The Alignment Healthcare share sale represented about 13.4% of Maroney Dawn Christine’s prior holding. The percentage is based on shares owned before the transaction.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.